US2008199448A1PendingUtilityA1
Enzyme composition for improving food digestion
Individually held — no corporate assignee on recordPriority: Feb 16, 2007Filed: Feb 15, 2008Published: Aug 21, 2008
Est. expiryFeb 16, 2027(~0.5 yrs left)· nominal 20-yr term from priority
A61K 9/4891A23V 2002/00A61K 38/465A61K 38/47A61K 38/48A61K 38/4873A61K 31/198A23L 29/06A23L 29/244A23L 33/175
34
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An orally administered composition for improving food absorption and digestion contains therapeutically effective dosages of digestive enzymes and L-glutamine as active ingredients. The digestive enzymes include at least one each of a lipase, a protease, and an amylase, and at least a portion of each of these enzymes is enteric coated.
Claims
exact text as granted — not AI-modified1 . An orally administered composition for improving the absorption and digestion of food, said composition comprising therapeutically effective dosages of digestive enzymes and L-glutamine as active ingredients;
wherein said digestive enzymes include at least one each of a lipase, a protease, and an amylase, and at least a portion of each of said lipase, protease, and amylase is enteric coated.
2 . The composition of claim 1 wherein said composition improves the digestion of food in the stomach and in the small intestine.
3 . The composition of claim 1 further comprising a therapeutical dosage of an oligosaccharide as an active ingredient.
4 . The composition of claim 1 wherein said protease includes bromelain, papain, or a combination thereof.
5 . The composition of claim 1 further comprising digestive enzymes selected from the group consisting of: β-glucanase, cellulase, glucoamylase, hemicellulase, invertase, lactase, malt diastase, phytase, and combinations thereof.
6 . The composition of claim 1 comprising a solid form.
7 . The composition of claim 6 wherein said solid form comprises a powder, a tablet, a capsule, a caplet, a sachet, or an encapsulated liquid.
8 . The composition of claim 7 wherein said solid form comprises a capsule.
9 . The composition of claim 1 further comprising at least one excipient as an inactive ingredient.
10 . The composition of claim 9 wherein said excipient is selected from the group consisting of a filler, a flow agent, a colorant, a flavoring, a dissolving agent, and combinations thereof.
11 . The composition of claim 9 wherein said excipient comprises up to about 95 weight percent of said composition.
12 . The composition of claim 9 wherein said excipient is selected from among rice maltodextrin, magnesium stearate, and combinations thereof.
13 . The composition of claim 1 comprising a capsule containing:
Classi-
Enzyme
fication
Origin
Activity (Units*)
Protease 6.0
Protease
Aspergillus spp.
9,500
FCC HUT
Protease 4.5
Protease
Aspergillus spp.
18,000
FCC HUT
Protease 3.0
Protease
Aspergillus spp.
92.4
FCC SAPU
Amylase
Amylase
Aspergillus spp.
3,000
FCC DU
Glucoamylase
Amylase
Aspergillus spp.
4.5
FCC AGU
Hemicellulase
Other
Aspergillus spp
320
FCC HCU
β-glucanase
Other
Aspergillus spp
5
FCC BGU
Phytase
Other
Aspergillus spp
21
FCC FTU
Lipase
Lipase
Rhizopus spp.
80
FCC LU
Cellulase
Other
Aspergillus spp
90
FCC CU
Lactase
Other
Aspergillus spp
100
FCC ALU
Invertase
Other
Saccharomyces
110
FCC SU
Malt Diastase
Amylase
Hordeum vulgare
225,000
FCC DP
Bromelain
Protease
Ananas comosus
250,000
FCC PU
Papain
Protease
Carica papaya
225,000
FCC PU
Protease 7.0
Protease
Bacillus spp.
896
FCC PC
(Enteric)
Lipase (Enteric)
Lipase
Rhizopus spp
64
FCC LU
Amylase 6.6
Amylase
Bacillus spp.
160
FCC BAU
(Enteric)
14 . The composition of claim 13 wherein said capsule further contains a fructooligosaccharide (FOS).
15 . The composition of claim 1 wherein said therapeutically effective dosage of glutamine comprises about 50 mg to about 500 mg.
16 . The composition of claim 15 wherein said therapeutically effective dosage of glutamine comprises about 100 mg to about 200 mg.
17 . The composition of claim 1 wherein at least a portion of each of said lipase, protease, and amylase is enteric coated using a formulation comprising hydroxypropyl phthalate and methylcellulose.Join the waitlist — get patent alerts
Track US2008199448A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.